 Home > Active Ingredient News > Digestive System Information > Consensus on the latest guidelines of the 6 liver disease departments, one article is included in the bag!

Consensus on the latest guidelines of the 6 liver disease departments, one article is included in the bag!

 Last Update: 2021-12-05
 Source: Internet
 Author: User

Tags

molecular cancer therapeutics

make nair work

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

This article summarizes the recently released domestic and foreign liver disease related guidelines for everyone to read and download! 2021 AGA Clinical Practice Guidelines: Management of coagulopathy in patients with liver cirrhosis In September 2021, the American Gastroenterology Association (AGA) issued guidelines for the management of coagulopathy in patients with cirrhosis
.

This guideline aims to provide guidance and suggestions for clinical problems related to the prevention and treatment of bleeding and thrombosis in patients with liver cirrhosis
.

Download link: http://guide.
medlive.
cn/guideline/24240 Recommended reading: Management of coagulopathy in patients with liver cirrhosis: 2021 AGA clinical practice guidelines released | Guidelines consensus multidisciplinary diagnosis and treatment of portal hypertension in liver cirrhosis (based on hepatic vein pressure gradient ) Expert consensus, Beijing Medical Doctors Association Portal Hypertension Specialist Branch, together with the Liver Disease Professional Committee of the Chinese Research Hospital Association, covers internal medicine, endoscopy, interventional, surgery, radiology and nursing experts from all over the country who are engaged in the diagnosis and treatment of liver cirrhosis and portal hypertension.
Consensus on relevant guidelines at home and abroad, drawing on the latest research progress at home and abroad in recent years, jointly formulating relevant diagnosis and treatment consensus on the basic concepts, pathophysiological basis, diagnosis, treatment and prevention of cirrhosis and portal hypertension, aiming to provide clinical work The best treatment plan and intervention measures
.

Download link: http://guide.
medlive.
cn/guideline/24285HBV/HCV-related hepatocellular carcinoma antiviral treatment expert consensus (updated in 2021) ) The progress of therapeutics, the Liver Cancer Group of the Hepatology Branch of the Chinese Medical Association has organized experts in related fields to update the "Expert Consensus on Antiviral Therapy of HBV/HCV Related Hepatocellular Carcinoma"
.

Based on previous expert recommendations/consensus, this version of the consensus analyzes new evidence results in recent years and forms relevant recommendations.
Relevant staff from primary medical institutions provide guidance and reference
.

Download link: http://guide.
medlive.
cn/guideline/24316 Recommended reading: 2021 update: HBV/HCV-related hepatocellular carcinoma antiviral therapy Expert consensus on diagnosis and treatment of chronic HBV infected patients with continuous normal ALT This consensus is based on China's "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2019 Edition)" supplements the latest developments in chronic hepatitis B in which alanine aminotransferase (ALT) continues to be normal, and aims to help clinicians maintain normal ALT in chronic hepatitis B Make reasonable diagnosis and treatment decisions in the diagnosis and treatment of patients
.

Download link: http://guide.
medlive.
cn/guideline/24362 "APASL Guidelines on Discontinuing Nucleoside (Acid) Analogues in Patients with Chronic Hepatitis B" Interpretation July 23, 2021, Asia Pacific Association of Liver Diseases (APASL) In its official journal Hepatology International, the full text of "APASL Guidelines for Discontinuing Nucleoside (Acid) Analogues in Patients with Chronic Hepatitis B" was published
.

This article provides a comprehensive interpretation of the guidance and compares it with the discontinuation criteria recommended in the chronic hepatitis B diagnosis and treatment guidelines such as APASL, the European Association of Liver Diseases, the American Association for the Study of Liver Diseases, and the Infectious Diseases Branch of the Chinese Medical Association/Hepatology Branch
.

Download link: http://guide.
medlive.
cn/guidelinesub/8446 "Asia-Pacific Hepatology Society Consensus Guidance: Budd-Chiari Syndrome" excerpts and translations Aiming at the characteristics of Budd-Chiari syndrome in the Asia-Pacific region, APASL has developed consensus guidelines for this department And put forward specific recommendations for clinicians
.

Download link: http://guide.
medlive.
cn/guidelinesub/8461

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.